CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Active and Passive Vaccination for Pulmonary Arterial Hypertension: A Novel Therapeutic Paradigm Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Chronic thromboembolic pulmonary hypertension Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Original ResearchVolume 7, Issue 6, June 2019

JOURNAL:JACC: Heart Failure Article Link

Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

C Balmforth, J Simpson, L Shen et al. Keywords: angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; etiology; heart failure; natriuretic peptide; sneprilysin; treatment

FULL TEXT PDF